Abstract
This paper points to a potential antagonism between Human T-lymphotropic virus 1 (HTLV-1) and John Cunningham virus (JCV). Similarities between HTLV1 protease and JCV capsid protein, when compared in silico, offer a possibility of an interaction between the two viral proteins which could influence lymphoma survival rates and the risk of developing this disease.